Thank you for visiting the Global Allergy and Airways Patient Platform website. On behalf of the members of GAAPP and its Executive body, I welcome you and invite you to explore this website, become more familiar with our network and share your ideas and concerns with us.
In 2009, a group of local and national asthma and allergy patient groups gathered in Buenos Aires, Argentina to establish GAAPP as a network linking organizations with a common interest: the support for and improvement of the quality of life of people around the globe who have allergies and asthma. Since then we have grown into a vibrant world-wide organization with over 30 constituent members from every continent sharing information and best practices, concerns and hopes.
While based in Vienna, Austria, our Board is representative of all regions of the world with large and small groups, all with a common purpose: empowering the patient and supporting the patient voice so that decision makers in both the public and private sectors, in government and industry will be mindful of patient needs, patient desires and patient rights.
While patient focused, we work in concert with healthcare professionals, researchers and scientists, industry and governments to further the aspirations of people with asthma and allergies. We acknowledge profound regional differences and work to support the aspirations of all patients regardless of where they live.
Our goal is to help patients and their families through their journey with asthma and allergies. Equally, we raise issues of concern to patients with national and international decision makers. We are a forum to share program and policy ideas.
I invite you to explore these pages, and our links to various international and national partners. We value your ideas and expressions of support, including financial support, as we work to increase the public awareness of asthma and allergies and improve the lives of those affected by them.
The importance of listening to the patient voice is critical and now it will be heard more than ever. I was selected for a three year term from 2020-2022, as the first patient advocate member to Global Initiative for Asthma (GINA).
Please do not hesitate to contact us with either questions or suggestions.